Professor Anders Björkman
Quick facts
Marketed products
- Artesunate + Amodiaquine · Infectious Disease
Artesunate and amodiaquine work synergistically to kill malaria parasites by disrupting their hemoglobin metabolism and interfering with their DNA replication. - Artesunate-amodiaquine given with single low dose primaquine
- Coadministered Artesunate plus Amodiaquine · Infectious Disease
Artesunate and amodiaquine work synergistically to kill malaria parasites through distinct mechanisms: artesunate generates reactive oxygen species that damage parasite proteins and DNA, while amodiaquine inhibits parasite heme detoxification.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about Professor Anders Björkman
What are Professor Anders Björkman's marketed drugs?
Top marketed products include Artesunate + Amodiaquine, Artesunate-amodiaquine given with single low dose primaquine, Coadministered Artesunate plus Amodiaquine.
Related
- Artesunate + Amodiaquine · Infectious Disease
- Artesunate-amodiaquine given with single low dose primaquine
- Coadministered Artesunate plus Amodiaquine · Infectious Disease
- Sector hub: All tracked pharma companies